Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00229658
Status:
COMPLETED
Last Update Posted:
2015-03-25
First Post:
2005-09-28
Brief Title:
An Observational Study Evaluating SYMLIN Pramlintide Acetate Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-09
Start Date Type:
None
Primary Completion Date:
2008-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-05
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-28
First Submit QC Date:
September 28 2005
Study First Post Date:
2005-09-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2009-06-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-03-05
Last Update Post Date:
2015-03-25
Last Update Post Date Type:
ESTIMATED